Table 4.
Feasibility aspects of the trial and intervention fidelity
| Measure | Australian sample, % (n/N) | Hong Kong sample |
|---|---|---|
| Feasibility | ||
| Recruitment rate (patients) | 10% (32/321) | 14.7% |
| Consent rate (patients) | 44% (32/72) | 47% |
| Retention rate (patients completing intervention/trial) | 81% (26/32) | 62% |
| Patients returning final assessments | 56% (18/32) | 48% |
| Proportion of patients with caregiver | 69% (22/32) |
100% (inclusion criterion) 83% (from screened sample) |
| Consent rate for eligible caregivers | 55% (12/22) | 100% (inclusion criterion) |
| Retention rate (caregivers completing trial) | 84% (10/12) | 61% |
| Caregivers returning final assessments | 67% (8/12) | 48% |
| Intervention fidelity | ||
| % patients attending all (3) appointments | 92% (11/12) | 62% |
| % caregivers attending all (3) appointments | 67% (4/6) | 62% |
| Adherence of appointments to timeframe | ||
| • Session 1 (completed within 2–3 weeks from baseline) | 42% (5/12) | All appointments were at fixed times through one home visiting and two phone calls for f/u |
| • Session 2 (completed within 4–6 weeks from baseline) | 58% (7/12) | |
| • Session 3 (completed within 6–8 weeks from baseline) | 50% (6/12) | |
| % patients with treatment goal | 100% | 100% |